StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.52−0.01 (-1.67%)

Close on Nov 17, 2026Market cap $14.24MP/E –Yield –

Citius Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Citius Pharmaceuticals's price to sales ratio was 379.3× on Jan 31, 2020.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Jan 31, 2020379.3×+51.4
2019Dec 31, 2019327.9×+103.3
2018Dec 31, 2018224.6×–

More Citius Pharmaceuticals figures

See a number that looks wrong?